207 related articles for article (PubMed ID: 35841931)
21. Identifying and Assessing Putative Allosteric Sites and Modulators for CXCR4 Predicted through Network Modeling and Site Identification by Ligand Competitive Saturation.
Inan T; Flinko R; Lewis GK; MacKerell AD; Kurkcuoglu O
J Phys Chem B; 2024 May; 128(21):5157-5174. PubMed ID: 38647430
[TBL] [Abstract][Full Text] [Related]
22. Machine learning approaches in predicting allosteric sites.
Nerín-Fonz F; Cournia Z
Curr Opin Struct Biol; 2024 Apr; 85():102774. PubMed ID: 38354652
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots).
MacKerell AD; Jo S; Lakkaraju SK; Lind C; Yu W
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129519. PubMed ID: 31911242
[TBL] [Abstract][Full Text] [Related]
24. Overview of Critical Parameters for the Design and Execution of a High-Throughput Screen for Allosteric Ligands.
Alt A
Curr Protoc Pharmacol; 2016 Sep; 74():9.20.1-9.20.23. PubMed ID: 27636112
[TBL] [Abstract][Full Text] [Related]
25. ProteinLens: a web-based application for the analysis of allosteric signalling on atomistic graphs of biomolecules.
Mersmann SF; Strömich L; Song FJ; Wu N; Vianello F; Barahona M; Yaliraki SN
Nucleic Acids Res; 2021 Jul; 49(W1):W551-W558. PubMed ID: 33978752
[TBL] [Abstract][Full Text] [Related]
26. Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response.
Tee WV; Guarnera E; Berezovsky IN
PLoS Comput Biol; 2018 Jun; 14(6):e1006228. PubMed ID: 29912863
[TBL] [Abstract][Full Text] [Related]
27. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
[TBL] [Abstract][Full Text] [Related]
28. Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.
Janero DR; Thakur GA
Expert Opin Drug Discov; 2016 Dec; 11(12):1223-1237. PubMed ID: 27712124
[TBL] [Abstract][Full Text] [Related]
29. Unmasking allosteric-binding sites: novel targets for GPCR drug discovery.
Casadó-Anguera V; Casadó V
Expert Opin Drug Discov; 2022 Aug; 17(8):897-923. PubMed ID: 35649692
[TBL] [Abstract][Full Text] [Related]
30. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
Pandey P; Roy KK; Doerksen RJ
J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
[TBL] [Abstract][Full Text] [Related]
31. Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs.
Bartuzi D; Kaczor AA; Matosiuk D
Methods Mol Biol; 2018; 1705():297-319. PubMed ID: 29188568
[TBL] [Abstract][Full Text] [Related]
32. Allosteric communication and signal transduction in proteins.
Wu N; Barahona M; Yaliraki SN
Curr Opin Struct Biol; 2024 Feb; 84():102737. PubMed ID: 38171189
[TBL] [Abstract][Full Text] [Related]
33. Computational approaches to mapping allosteric pathways.
Feher VA; Durrant JD; Van Wart AT; Amaro RE
Curr Opin Struct Biol; 2014 Apr; 25():98-103. PubMed ID: 24667124
[TBL] [Abstract][Full Text] [Related]
34. Progress in Allosteric Database.
Song K; Zhang J; Lu S
Adv Exp Med Biol; 2019; 1163():65-87. PubMed ID: 31707700
[TBL] [Abstract][Full Text] [Related]
35. Allosteric drugs: New principles and design approaches.
Tee WV; Berezovsky IN
Curr Opin Struct Biol; 2024 Feb; 84():102758. PubMed ID: 38171188
[TBL] [Abstract][Full Text] [Related]
36. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
Huang W; Nussinov R; Zhang J
Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
[TBL] [Abstract][Full Text] [Related]
37. Identification of potential allosteric communication pathways between functional sites of the bacterial ribosome by graph and elastic network models.
Guzel P; Kurkcuoglu O
Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3131-3141. PubMed ID: 28917952
[TBL] [Abstract][Full Text] [Related]
38. Advances in the Computational Identification of Allosteric Sites and Pathways in Proteins.
Daura X
Adv Exp Med Biol; 2019; 1163():141-169. PubMed ID: 31707703
[TBL] [Abstract][Full Text] [Related]
39. Computational Advances for the Development of Allosteric Modulators and Bitopic Ligands in G Protein-Coupled Receptors.
Feng Z; Hu G; Ma S; Xie XQ
AAPS J; 2015 Sep; 17(5):1080-95. PubMed ID: 25940084
[TBL] [Abstract][Full Text] [Related]
40. Allostery at opioid receptors: modulation with small molecule ligands.
Livingston KE; Traynor JR
Br J Pharmacol; 2018 Jul; 175(14):2846-2856. PubMed ID: 28419415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
